Michael Lehmicke
Latest From Michael Lehmicke
Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers
As more regenerative medicine products approach clinical testing and commercialization, stakeholders in the field are increasingly pressed to address substantial challenges, including pricing and reimbursement, GMP manufacturing, and clinical availability, and patient accessibility to these life changing therapies.